Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Urology. 2015 Feb;85(2):337–342. doi: 10.1016/j.urology.2014.08.048

Table 2. AUC of PSA and PSA velocity.

Dutasteride Placebo
2 years Any cancer High grade Any cancer High grade
 PSA 0.616 (0.582, 0.650) 0.681 (0.627, 0.735) 0.603 (0.573, 0.632) 0.676 (0.628, 0.725)
 PSAv 0.631 (0.596, 0.666) 0.710 (0.657, 0.763) 0.584 (0.554, 0.615) 0.658 (0.608, 0.708)
 OLS Log PSAv 0.621 (0.587, 0.655) 0.709 (0.659, 0.758) 0.571 (0.541, 0.600) 0.634 (0.585, 0.683)
 PSA+PSAv 0.605 (0.571, 0.639) 0.663 (0.609, 0.718) 0.598 (0.568, 0.628) 0.671 (0.621, 0.721)
 PSA+ OLS Log PSAv 0.626 (0.592, 0.661) 0.706 (0.652, 0.759) 0.595 (0.565, 0.625) 0.656 (0.606, 0.706)
4 years
 PSA 0.600 (0.550, 0.650) 0.634 (0.540, 0.729) 0.584 (0.539, 0.629) 0.697 (0.615, 0.779)
 PSAv 0.636 (0.586, 0.686) 0.724 (0.643, 0.804) 0.609 (0.563, 0.655) 0.722 (0.639, 0.805)
 OLS Log PSAv 0.658 (0.609, 0.707) 0.716 (0.629, 0.804) 0.598 (0.550, 0.645) 0.653 (0.556, 0.750)
 PSA+PSAv 0.610 (0.560, 0.660) 0.626 (0.529, 0.723) 0.576 (0.531, 0.620) 0.680 (0.598, 0.761)
 PSA+ OLS Log PSAv 0.654 (0.605, 0.703) 0.707 (0.618, 0.796) 0.590 (0.543, 0.638) 0.679 (0.584, 0.774)